ISUS:LSE:LSE-iShares MSCI USA Islamic UCITS (GBX)

ETF | Others |

Last Closing

USD 5578.5

Change

-27.50 (-0.49)%

Market Cap

USD 0.23B

Volume

833.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-1.51 (-0.53%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

-2.00 (-1.06%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+1.31 (+0.94%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.31 (-1.69%)

USD 510.38B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.19 (-1.34%)

USD 510.38B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.75 (-1.07%)

USD 266.08B
0QZO:LSE 0QZO

-0.25 (-0.26%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.54 (-1.74%)

USD 210.67B
0QZ3:LSE Qualcomm Inc.

-4.02 (-2.34%)

USD 202.26B

ETFs Containing ISUS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.41% 40% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.41% 40% F 47% F
Trailing 12 Months  
Capital Gain 11.05% 35% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.05% 36% F 42% F
Trailing 5 Years  
Capital Gain 64.07% 74% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 64.07% 74% C 74% C
Average Annual (5 Year Horizon)  
Capital Gain 12.40% 73% C 74% C
Dividend Return 12.72% 74% C 74% C
Total Return 0.32% 41% F 49% F
Risk Return Profile  
Volatility (Standard Deviation) 8.16% 75% C 86% B+
Risk Adjusted Return 155.95% 100% F 100% F
Market Capitalization 0.23B 62% D 35% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.